Dunlop A. Sinclair Insider Trading Activity
Corporate InsiderDirector · CIK 1721108
Performance Scorecard
Forward stock performance after each transaction by Dunlop A. Sinclair. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | +3.4% | 67% | 3 |
| 90 days | — | -9.6% | 0% | 3 |
| 120 days | — | +4.1% | 67% | 3 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersAPLS · Apellis Pharmaceuticals, Inc.
🔒 Subscribe to see trade entries
Pro members see exactly when Dunlop A. Sinclair bought and sold APLS.
Upgrade to ProRecent Trades
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| APLS | Apellis Pharmaceuticals, Inc. | 3 | $2.2M |
Other insiders at Apellis Pharmaceuticals, Inc.
8 other tracked filers at APLS.
Watson David O.
General Counsel
11
Trades
Francois Cedric
CEO
8
Trades
Sullivan Timothy Eugene
CFO
6
Trades
Chopas James George
VP
5
Trades
Delong Mark Jeffrey
Chief Business & Strat Officer
4
Trades
Nicholson Nur
Chief Technical Officer
3
Trades
Baumal Caroline
Chief Medical Officer
3
Trades
Deschatelets Pascal
Chief Scientific Officer
3
Trades